Diclofenac Sodium and Misoprostol 75 mg/1 (Diclofenac Sodium and Misoprostol TABLET, DELAYED RELEASE) 75 mg/1

Diclofenac Sodium and Misoprostol 75 mg/1 is a delayed-release tablet combining two active ingredients for managing pain and inflammation. This medication is often used for conditions requiring both pain relief and gastrointestinal protection.

Strength

75 mg/1

Pack Size

60 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0591-0398-60)

Manufacturer / TM Owner

Actavis Pharma, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Diclofenac Sodium and Misoprostol 75 mg/1 is primarily used for pain relief and reducing inflammation. The diclofenac component helps manage pain and inflammation, while misoprostol protects the stomach lining. This combination is often prescribed for conditions where both pain management and gastrointestinal protection are needed.

Side Effects

Common effects of Diclofenac Sodium and Misoprostol 75 mg/1 may include stomach upset, diarrhea, and headaches. Some users might experience dizziness or mild nausea. These effects vary and are not experienced by everyone.

Precautions & Warnings

Handle Diclofenac Sodium and Misoprostol 75 mg/1 with care, especially if you have a history of stomach ulcers or bleeding disorders. Always follow the guidance of a healthcare professional regarding its use and storage.

Avoid Interactions

Diclofenac Sodium and Misoprostol 75 mg/1 may interact with other medications, including blood thinners and certain pain relievers. Alcohol consumption should be avoided as it can increase the risk of stomach irritation.

Frequently Asked Questions

Diclofenac Sodium and Misoprostol is used for pain relief and reducing inflammation, often in conditions requiring gastrointestinal protection.

Diclofenac Sodium and Misoprostol should be taken orally, typically with food to minimize stomach upset. Follow the instructions provided by your healthcare professional.

Common side effects may include stomach upset, diarrhea, headaches, dizziness, and mild nausea.

It is generally advised to avoid alcohol while taking Diclofenac Sodium and Misoprostol, as it can increase the risk of stomach irritation.

Individuals with a history of stomach ulcers, bleeding disorders, or allergies to any of the components should avoid taking Diclofenac Sodium and Misoprostol.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.